Ondansetron Hydrochloride Injection Shortage

• • Ondansetron injection, Hikma, 2 mg/mL, 20 mL vial, 1 count, NDC 00641-6079-01
  • Ondansetron injection, Pfizer, 2 mg/mL, 2 mL vial, 25 count, NDC 00409-4755-03
  • Ondansetron injection, Pfizer, 2 mg/mL, 20 mL vial, 1 count, NDC 00409-4759-01

• • Apotex has ondansetron injection available.
  • Avet has ondansetron injection available.
  • AuroMedics is no longer marketing ondansetron injection.
  • Fosun has ondansetron injection available.
  • Fresenius Kabi has ondansetron injection available.
  • Hikma did not provide a reason for the shortage.
  • Viatris discontinued ondansetron 2 mL vials in December 2021 and the 20 mL vials were discontinued in June 2022.
  • Pfizer has ondansetron injection on back order due to manufacturing delays.
  • Sagent has ondansetron injection available. The 20 mL vials were discontinued in 2021.
  • Novartis discontinued Zofran 20 mL vials in May 2018.

• • Ondansetron injection, Apotex, 2 mg/mL, 2 mL vial, 25 count, NDC 60505-6130-05
  • Ondansetron injection, Avet Pharmaceuticals, 2 mg/mL, 2 mL vial, 25 count, NDC 23155-0547-42
  • Ondansetron injection, Avet Pharmaceuticals, 2 mg/mL, 20 mL vial, 1 count, NDC 23155-0549-31
  • Ondansetron injection, Fosun Pharma, 2 mg/mL, 2 mL vial, 25 count, NDC 72266-0123-01
  • Ondansetron injection, Fosun Pharma, 2 mg/mL, 20 mL vial, 1 count, NDC 72266-0124-01
  • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL RFID prefilled syringe, 24 count, NDC 76045-0216-20
  • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL vial, 25 count, NDC 63323-0373-02
  • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 1 count, NDC 63323-0374-20
  • Ondansetron injection, Hikma, 2 mg/mL, 2 mL vial, 25 count, NDC 00641-6078-25
  • Ondansetron injection, Sagent, 2 mg/mL, 2 mL vial, 25 count, NDC 25021-0777-02

Estimated Resupply Dates

• • Hikma has ondansetron 2 mg/mL 20 mL vials on back order and the company estimates a release date of mid-May 2024.
  • Pfizer has ondansetron 2 mg/mL 2 mL and 20 mL vials on back order and the company estimates a release date of June 2024 for the 2 mL vials and July 2024 for the 20 mL vials.